TSLA
Tesla
-- 412.840 NVDA
NVIDIA
-- 135.340 MSTR
MicroStrategy
-- 296.132 FFIE
Faraday Future Intelligent Electric Inc.
-- 2.9312 RGTI
Rigetti Computing
-- 16.1350 
NEWS
Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting
Compass Therapeutics (Nasdaq: CMPX), a clinical-stage oncology-focused biopharmaceutical company, announced the acceptance of an abstract for poster presentation at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting. The meeting will be held from November 8–10, 2024, in Houston, TX.
The poster presentation, titled 'Pharmacodynamic and Response Biomarkers in the Monotherapy Arm of a Phase 1 Trial of CTX-471, a Novel Anti-CD137 Agonist Antibody', will be presented on Friday, November 8, 2024, from 9:00 AM to 7:00 PM CDT in Exhibit Halls AB. The presentation materials will be available on the company's website after the presentation concludes.
The poster presentation, titled 'Pharmacodynamic and Response Biomarkers in the Monotherapy Arm of a Phase 1 Trial of CTX-471, a Novel Anti-CD137 Agonist Antibody', will be presented on Friday, November 8, 2024, from 9:00 AM to 7:00 PM CDT in Exhibit Halls AB. The presentation materials will be available on the company's website after the presentation concludes.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment